Approval was based on results from multiple studies, which demonstrated a slowing of cognitive decline in patients with ...

Campaign encourages the use of low-dose aspirin to help reduce the risk of preeclampsia and the complications that come with ...

A surge in biotech startup out-licensing deals from the country are paving the way for increased IPO and M&A activities.

Under terms of the deal, AbbVie will provide Neomorph with an upfront payment and the potential to earn up to $1.64 billion ...

Application is supported by results from the DEVOTE study, which suggested that two doses of Spinraza (nusinerse) 50 mg taken ...

As part of the regulatory action, memantine/donepezil extended-release capsules have been granted a 180-day exclusivity in ...

Trial findings show long-term recurrence-free survival in patients with low-grade upper tract urothelial cancer treated with ...

CIII nasal spray, marking the first monotherapy to be approved for adults with treatment-resistant depression (TRD).

The cobas liat test aims to improve patient outcomes by offering rapid, accurate results in decentralized and community-based ...

The trial, developed in collaboration with Novotech, will specifically target dietary and alcohol-induced overindulgence.

Cary Claiborne, CEO, Adial Pharmaceuticals, discusses AD04’s development timeline and next steps towards approval for alcohol ...

Arvinas, Inc, announced that its chief commercial officer, John Northcott, is stepping down as of mid-January. 1 While the ...